Oramed Pharmaceuticals
ORMP
#8952
Rank
NZ$0.26 B
Marketcap
NZ$6.55
Share price
0.26%
Change (1 day)
69.35%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$25.63 Million a decrease over its 2023 earnings that were of NZ$12.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-485.8%
2024 -NZ$25.63 Million-311.47%
2023 NZ$12.11 M-119.45%
2022 -NZ$62.29 Million39.17%
2021 -NZ$44.76 Million73.93%
2020 -NZ$25.74 Million18.53%
2019 -NZ$21.71 Million-16.62%
2018 -NZ$26.04 Million38.32%
2017 -NZ$18.83 Million12.51%
2016 -NZ$16.73 Million25.01%
2015 -NZ$13.39 Million18.18%
2014 -NZ$11.33 Million39.72%
2013 -NZ$8.11 Million46.4%
2012 -NZ$5.54 Million128.32%
2011 -NZ$2.43 Million-51.47%
2010 -NZ$5 Million35.21%
2009 -NZ$3.7 Million
2007 -NZ$5.82 Million607.04%
2006 -NZ$0.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$35.64 B 35,853.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$13.09 B 13,105.89%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion-973.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$46.87 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel